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TECHNICAL NOTES
The two-stage brachial artery–brachial vein
autogenous fistula for hemodialysis: An alternative
autogenous option for hemodialysis access
Niren Angle, MD, and Ankur Chandra, MD, San Diego, Calif
The optimal dialysis access for the patient with chronic renal failure is considered to be an autogenous fistula; this is
reflected in the recommendations of the National Kidney Foundation–Disease Outcomes Quality Initiatives (NKF-
DOQI). If adequate superficial veins at the wrist or the forearm are not available, the next option is usually a prosthetic
arteriovenous graft. In this case series, we describe our experience with an autogenous fistula constructed using the
brachial vein. There were 20 patients over a 14-month period who were operated on for dialysis access. In these patients,
no adequate superficial veins were found at operation. Instead of using a prosthetic graft, we performed a brachial
artery–brachial vein fistula in two stages. The first stage involved a forearm anastomosis and then subsequently, weeks
later, this fistula was “superficialized.” Twenty patients underwent a brachial artery–brachial vein fistula. Of these
patients, all had successful maturation of their fistula and after a minimumwaiting period of 12 weeks for maturation; all
but one were able to be successfully dialyzed through their fistula. One patient developed arm swelling due to previously
placed subclavian vein pacemaker wires. None of the other patients developed arm swelling or vascular steal. The brachial
artery–brachial vein fistula is a feasible option for hemodialysis access and we suggest that this option be considered
before a prosthetic arteriovenous graft is inserted. Arm swelling and steal have not been a problem, and all patients have
been able to have full dialysis through the fistula after appropriate maturation times. ( J Vasc Surg 2005;42:806-10.)Dialysis access complications account for a very high
percentage of hospitalizations in chronic renal failure pa-
tients.1,2 Of these complications, dialysis access failures
comprise a significant number of these hospital admissions.
In 1997, the National Kidney Foundation (NKF) through
its Disease Outcomes Quality Initiative (DOQI) guidelines
attempted to provide some evidence-based guidance to
clinicians and to reduce practice variations.2 Fundamental
in these guidelines was the recommendation that of new
renal failure patients, at least 50% should have a primary
fistula constructed, given the superior patency of fistulae
over prosthetic grafts.
The ability to construct a usable fistula depends on
many things, not least among which is the availability of
adequate superficial veins. In our practice, routine ultra-
sound vein mapping is performed, and the fistula is con-
structed at the site of the most suitable vein. Options for
fistulae are the traditional radiocephalic fistula, brachioce-
phalic fistula, brachiobasilic fistula, and the occasional
transposed radiobasilic fistula. If none of these options is
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806possible, traditionally, the next step has been the insertion
of a prosthetic graft in the forearm or upper arm.
Due to the dismal patency rates for grafts, we began
performing brachiobrachial fistulae, in which one of the
paired brachial veins, ie, the venae comitantes flanking the
brachial artery, is sutured to the brachial artery in the
antecubital fossa, and then subsequently in a separate op-
eration, the maturing brachial vein is superficialized. This
article describes 20 such patients in whom we have per-
formed this operation with success.
PATIENT AND METHODS
From November 2002 until December 2004, 20 pa-
tients had a brachiobrachial fistula performed for dialysis
access. Of the 18 patients, all but one had already initiated
dialysis through a catheter as they had presented for the first
time in renal failure. The one patient that was an exception
was a 46-year-old man with declining renal function and
anticipating dialysis in the near future. All 19 patients who
had a tunneled dialysis catheter had it dwelling in the
internal jugular vein as is the routine practice. These pa-
tients comprise the entire group of patients in our clinical
practice who have undergone this operation. There were
two other patients in whom the deep veins were explored
and were thought to be too small for this procedure and
those patients, both of them women, underwent an ipsilat-
eral upper arm prosthetic arteriovenous graft.
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gery for the first time, and in preparation, all had under-
gone ultrasound vein mapping. The routine vein mapping
that is done for the dialysis access planning examines the
superficial veins in both upper extremities and evaluates
patency and diameter. No attempt is made to examine the
deep veins, ie, the brachial veins. It is our preference to
approach the best vein, as assessed by ultrasound mapping,
the first time and not to necessarily start on the most distal
site on the nondominant arm in contrast to traditional
dogma.
In all 20 patients, ultrasound mapping suggested an
adequate or marginal (ie, 2.0 mm) cephalic or basilic
vein. With an anticipation that an adequate superficial vein
would be found, the superficial veins were explored on the
relevant side through a transverse incision one finger-
breadth below the antecubital crease.
In these 20 patients, on exploration no suitable ce-
phalic or basilic vein was found in the antecubital fossa. The
vein was either smaller than the ultrasound suggested or
chronically inflamed with a thickened wall. On exploration
of the brachial artery and its flanking brachial veins, there
was found a usable brachial vein(s). In the absence of
preoperative ultrasound measurement, we can only esti-
mate that the size of the brachial vein was at least 2.5 mm as
gauged by the ability to accommodate a 2.5-mm coronary
dilator.
Technique. All operations were done under local an-
esthesia with monitored anesthesia care. A transverse inci-
sion is made approximately one fingerbreadth below the
antecubital fossa. In these cases, the search for the antici-
pated superficial veins being fruitless, the bicipital aponeu-
rosis was opened and the brachial artery exposed. The
flanking veins were carefully exposed and dissected for an
adequate length. The larger of the veins was chosen for the
fistula; if they were of equal caliber and quality, the medial
brachial vein was used preferentially. The vein was divided
and sutured to the brachial artery in an end vein to side
artery configuration with a 7-0 Prolene suture. This con-
cluded the first stage of the operation.
Approximately 6 weeks later, the patient underwent a
second operation for “superficialization” of the fistula. This
operation was also done under local anesthesia and intrave-
nous sedation. At that time, through a medial incision on
the arm, the brachial vein was mobilized by dividing all
tributaries between silk sutures. During this operation, it is
critical that one does not divide a tributary that may repre-
sent the main inflow from the arteriovenous anastomosis. A
useful method of ensuring this is to occlude the tributary
with a DeBakey forceps and ensure that a strong thrill
remains in the fistula. After all the tributaries have been
divided, the maturing vein is able to assume a more super-
ficial position. We make no attempt to tunnel it laterally as
it tends to cause a loss of length in amount of fistula
available for cannulation. We merely create a small flap in
the subcutaneous tissue on the anterior aspect of the inci-
sion and “tuck” the vein in by putting interrupted 3-0
absorbable sutures in the subcutaneous tissue to house thevein, always making double sure that there is no acute
angulation or kink of the vein. The incision is then closed
with a 3-0 absorbable suture and staples. No drains are
used. The skin is allowed to heal, and the fistula is not used
for 12 weeks from the time of the first operation.
RESULTS
Twenty patients underwent this operation, and all of
them were done under local anesthesia with sedation. Ad-
ditionally, all the patients had the operation done in two
stages as described above. There were eight women and 12
men. The mean age of the patients was 51 16 years (range,
25-77). The risk factors for the development of chronic renal
failure were as follows: hypertension (17/20), diabetes melli-
tus (12/20), and polycystic kidney disease (2/20). None of
these patients had had any previous attempt at surgical
access, save the tunneled catheter placement. Of the 19
patients who were already on dialysis and were being dia-
lyzed through a tunneled catheter, 18 patients had an
indwelling right internal jugular vein catheter. Thirteen
patients had the fistula placed in the right arm and the
remaining six patients had it placed in the left arm. The
mean follow-up was 14  4 months (range, 8-23).
In all these cases, the decision to perform the brachio-
brachial fistula was made intraoperatively based on our
finding of “inadequate superficial veins.” In the 20 patients
described here, the preoperative vein mapping indicated
only one superficial vein as patent and possibly of adequate
caliber. Specifically, in 15 patients, the vein was either not
of an adequate caliber or had a significant length of stenosis
or stricture upstream of the antecubital fossa, when evalu-
ated at the time of operation. In the other five patients, the
vein was patent and appeared to be of usable caliber but had
an inflamed appearance, ie, the wall of the vein was white
and thickened. For this reason, a fistula using the superficial
veins in these patients was thought to be unlikely to mature.
The second stage operation was done approximately 6
weeks later in all these patients. No imaging of the fistula
was performed between the first and second operations.
The NKF-DOQI recommendations suggested an ideal
waiting time for fistula cannulation of approximately 3 to 4
months and in concert with this, we like to ideally wait 3
months before cannulating fistulae. By this time, all the
incisions have healed.
No patient developed a steal syndrome. Except for one
patient, none of the patients developed signs of significant
or prolonged arm swelling. The one patient developed
severe venous hypertension in the presence of a patent
fistula. A venogram was performed that revealed a severe
stenosis of the ipsilateral subclavian vein. This patient had
indwelling pacemaker wires traversing that subclavian vein;
his preoperative venous duplex had shown no signs of
venous obstruction. A balloon angioplasty of the vein was
successful for only 1 week, after which the swelling began to
recur. Due to the pacemaker wires, there was a great
reluctance to place a metallic stent in apposition within the
vein. The fistula was ligated and parenthetically was noted
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swelling abated within days of the fistula ligation.
In the remaining patients, the mean time to cannula-
tion of the fistula was 13 1 weeks. The primary functional
access patency in this group, to date, as defined by the
Society for Vascular Surgery and American Association for
Vascular Surgery in their reporting standards for recom-
mended standards for reports dealing with arteriovenous
hemodialysis accesses is 95%.3 Successful hemodialysis was
performed and continues to be performed in all these
patients. There were no secondary interventions performed
in any of these patients, other than the superficialization
procedure.
DISCUSSION
Chronic renal failure and the need for dialysis remain
one of the most vexing problems facing clinicians, both
nephrologists and surgeons. Even with renal replacement
therapy, end-stage renal disease patients have a significantly
shorter life expectancy across quartiles of age. Successful
construction and maturation of a dialysis fistula are neces-
sary prerequisites for these patients to survive their dimin-
ished life span, short of transplantation.
It is clear that autogenous fistulae, should they mature
successfully, have a significantly superior patency rate and
also require much less in the way of secondary interven-
tions. Dialysis access surgery has evolved considerably, par-
ticularly due to the impetus of the NKF-DOQI guidelines.
There is a much stronger emphasis and a more insistent
search for adequate veins so that a fistula may be created.
Certainly, in patients who have had no dialysis access sur-
gery before, it is much more predictable that an autogenous
fistula will be successfully constructed. This preference for
an autogenous fistula has led many to perform some inno-
vative access operations such as the use of the translocated
femoropopliteal vein, which was reported by Huber et al.3
However, this operation had some significant morbidity
including a 43% incidence of hand ischemia. Bazan and
Schanzer8 recently reported on two patients in whom a
brachial artery–brachial vein fistula was performed with
good results, patients in whom no superficial veins were
available. We have been using this operation in patients
over the past 2 years, and although our technique differs
somewhat from that of Bazan and Schanzer, we have been
satisfied with the success of the brachial artery–brachial vein
fistula.
The preoperative vein mapping is very important in this
regard as it allows one to choose the best vein the first time
rather than the traditional approach that places a high value
on starting the quest in the nondominant arm, in the most
distal available vein, reserving other sites for subsequent
remedial operations.5,6 We approach access surgery with
preoperative ultrasound vein mapping as the principal
guide as to which arm and which vein to use, with the intent
being to perform the best operation the first time using the
best vein. Although in these patients, the vein mapping was
not sufficiently predictive, this is a small portion of a large
denominator of patients with dialysis access, and in theoverwhelming majority of patients, ultrasound vein map-
ping is very useful and allows the best access procedure to
be done the first time. We have since modified the tech-
niques of ultrasound vein mapping such that a complete
visualization of the veins is performed from wrist to axilla as
opposed to segmental interrogation of the vein at specific
sites as was done in these patients.
Accordingly, we obtain routine comprehensive vein
mapping in almost all patients. Imaging of the brachial
veins is not routinely done as part of the vein mapping
procedure, and in the setting of marginal superficial veins or
absent/thrombosed superficial veins, we will now institute
this selectively as part of the study. In the majority of these
patients, the putative superficial vein was either smaller than
suggested by ultrasound mapping or of the diameter sug-
gested by ultrasound mapping but chronically inflamed and
thickened and thus unsuitable. In these 20 patients, we
were unable to find a suitable superficial vein, and in
attempting to avoid the placement of a prosthetic graft in
the first two patients with small veins and small arteries, we
proceeded with the brachial artery–brachial vein fistulae.
We were pleasantly surprised at the success of the fistula, the
lack of any visible arm swelling above and beyond that of
any other arm fistula, and the ease of the operation. Since
then, it is our preference to perform this operation before
resorting to an upper arm graft. The body habitus of the
patient as well as the size of the vein and artery may affect
one’s decision on whether to perform this operation. Ob-
viously, the caliber of the vein is an important determinant
of whether to use it for a fistula. An overweight or obese
patient with a fat arm is the one patient in whom to avoid
this operation. The reason is that because of the amount of
subcutaneous fat, elevation/superficialization of the vein
results in a significant loss of length of the vein as it begins
to travel from deep to the fascia to the subcutaneous level.
A few technical points are worth mentioning. It is our
clinical impression that mobilization of the vein after it has
had a chance to mature results in less trauma to the vein and
perhaps better long-term patency; hence, our preference
for the 6-week interval between the arteriovenous anasto-
mosis and the superficialization of the vein. In an article
attempting to determine whether a traditional one-stage
brachiobasilic fistula had any difference in patency com-
pared to a staged superficialization of the brachiobasilic
fistula, El-Mallah4 noted a significant difference in patency
of 60% vs 90%, respectively.4 It is not unreasonable to apply
the same principle to that of superficialization/elevation of
the brachial vein. It is also extremely important that, as one
is mobilizing the brachial vein that is principally matured,
not to ligate any tributaries that may represent the inflow
from the brachial artery (Fig 1).
The incision during the second stage of the operation is
made in a vertical fashion between the biceps and the
triceps and extends from just above the antecubital crease
all the way up to just below the axillary crease. All the
tributaries are ligated and divided. Once the vein is mobi-
lized along its length, a subcutaneous flap is created later-
ally and the vein is placed in this flap. Interrupted sutures
g ve
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sionally, there may not be enough length for this flap, and
in those cases, we merely close the tissues under the vein
and place the fistula directly under the incision, which is
Fig 1. a, The exposure of the left antecubital fossa belo
paired brachial venae comitantes. Care must be taken t
subsequently contribute to the fistula outflow. b, The exp
It is important to note the outflow through the branchin
Fig 2. a, This cross section of the right arm displays
location under a tissue flap. b, The completed location o
the subcutaneous layer and the skin layer.then closed in two layers (Fig 2). Alternatively, the veindoes not have to placed in this pocket; it can merely be
“elevated” in that the soft tissue underneath the fistula is
closed with a running 3-0 absorbable suture and the skin is
closed over the vein. This places the fistula directly under
e bicipital aponeurosis revealing the brachial artery and
divide the branching vein during exposure as this will
after the completed brachial artery–brachial vein fistula.
in to the paired brachial veins.
uperficialized mature brachial vein in its subcutaneous
superficialized brachial vein fistula after closure of bothw th
o not
osurethe s
f thethe scar and can be accessed successfully. This “fistula
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lic transposition and, in fact, is ideal for an overweight
patient.7 The dialysis technicians have not had any difficulty
accessing these fistulae. All these operations are easily done
under local anesthesia with sedation as an outpatient.
In the standard algorithm, if the antecubital fossa is
explored and no adequate superficial veins are found, the
usual next option is a prosthetic arteriovenous graft. The
attempt to create this fistula does not eliminate that possi-
bility. In 6 weeks during the superficialization procedure, if
the vein is judged to not have matured to the point of
satisfaction or is thought to be inadequate in terms of
length, it is very easy to place an upper arm arteriovenous
prosthetic graft. We suggest that the possibility of placing
an autogenous fistula take priority over the adherence to
the traditional dogma of site preservation for future access,
which has failure of access as one of its guiding precepts.
Although most access does not last forever, even fistulae, it
is clear that an autogenous fistula will last longer and do so
with a lesser chance of requiring secondary interventions
than prosthetic grafts.
This operation can be done under local anesthesia with
intravenous sedation and as an outpatient, and all the
patients have tolerated this well. The brachial artery–
brachial vein fistula can be performed either as described
by Bazan and Schanzer8 or as described in this report, but
no matter which technique is chosen, we suggest that the
brachial artery–brachial vein fistula holds promise as yet
another option for autogenous dialysis access in the patient
with chronic renal failure.
Admittedly, the follow-up to date is limited but quite
encouraging in terms of both success of fistula maturation
and the absence of significant complications. To our knowl-edge, this report represents the largest series of patients
with end-stage renal disease with brachiobrachial fistulae in
the English literature. In the patient in whom superficial
veins are inadequate or absent, more likely than not, in
these patients, the deep veins are likely to be of good size
and caliber and this approach, if adopted, promises to place
the prosthetic graft as an even more remote option for
dialysis access. We suggest that this operation represents yet
another good option for autogenous fistulae and highly
recommend its incorporation into the algorithm for dialysis
access surgery.
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